Quantcast
Last updated on April 25, 2014 at 5:25 EDT

Latest Diabetes mellitus type 2 Stories

2012-03-23 02:22:49

SAN DIEGO and INDIANAPOLIS, March 23, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted marketing authorization to BYETTA® (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents. "The...

2012-03-22 06:25:24

GREENVILLE, N.C., March 22, 2012 /PRNewswire-USNewswire/ -- More than 8 percent of U.S. adults have diabetes. In North Carolina, the rate is even higher, at 9.6 percent. Among the state's African American adults, the rate is a staggering 15.6 percent.[1] In rural eastern North Carolina, the toll is even greater: the adjusted mortality rate from diabetes is 42 times higher than in other areas. Ten years ago, a small group of clinicians, diabetes educators and practice managers from...

2012-03-09 07:00:00

PARSIPPANY, N.J., March 9, 2012 /PRNewswire/ -- Chef Franklin Becker of the Two Reasons, One Recipe campaign is pleased to name Lorin Cook of Alpine, N.J. the grand prize winner of the Franklin's Family Fixin's Contest in which adults living with type 2 diabetes and/or high LDL cholesterol - or their family, friends or caretakers - were invited to receive a healthy makeover of their traditional family favorites. To view the multimedia assets associated with this release, please click:...

2012-03-08 10:47:31

International phase 3 trial is largest study ever of rare endocrine disorder A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results of the clinical trial conducted at centers on four continents appear in the March 8 New England Journal of Medicine and show that treatment with pasireotide cut cortisol secretion an average of 50 percent and returned...

2012-03-08 10:39:48

Metformin treatment seen to prevent growth of calcium deposits in coronary arteries Treatment with the common diabetes drug metformin appears to prevent progression of coronary atherosclerosis in patients infected with HIV. In a presentation today at the 19th Conference on Retroviruses and Opportunistic Infections, Massachusetts General Hospital (MGH) researchers reported that study participants receiving daily doses of metformin had essentially no progression of coronary artery...

2012-03-07 07:00:00

RIDGEFIELD, Conn. and INDIANAPOLIS, March 7, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Jentadueto(TM) (linagliptin/metformin hydrochloride) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S. JENTADUETO is a new prescription medication for patients who need to control their blood sugar. Taken twice daily, it combines two diabetes medicines - the dipeptidyl...

2012-02-29 07:00:00

SAN DIEGO, Feb. 29, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is participating in the fifth annual international Rare Disease Day to demonstrate the Company's support for patients and families who are impacted by rare diseases. Celebrated around the world today, Rare Disease Day aims to raise awareness of the more than 7,000 known rare diseases and the effects of these diseases on patients' lives, and to provide a platform of unity for...

2012-02-28 09:00:00

BOSTON, Feb. 28, 2012 /PRNewswire/ -- The Food and Drug Administration advisory panel voted on Wednesday, Feb. 22, 2012, in favor of recommending that the FDA approve the prescription obesity drug Qnexa. If approved, this will be the first time in more than a decade that a prescription weight-loss medication receives FDA approval. This landmark recommendation prompted the 2012 Cardiometabolic Health Congress (CMHC) expert faculty to weigh in on the implications of the potential approval of...

2012-02-27 08:00:00

CINCINNATI, Feb. 27, 2012 /PRNewswire/ -- Health care professionals tend to underestimate a patient's willingness to discuss their weight and treatment options(1). To help address this communication gap, the American College of Physicians Foundation has developed a Patient Centered Education guidebook and DVD called "Live Healthier - Weight Loss Options for Treating Obesity." This tool was supported by funding from Ethicon Endo-Surgery, Inc., (EES), a leader in bariatric and metabolic...

2012-02-23 12:40:00

WASHINGTON, Feb. 23, 2012 /PRNewswire-USNewswire/ -- Members of the Obesity Care Continuum (OCC) are pleased with the FDA's Advisory Committee near unanimous vote to approve QNEXA, a new drug to treat those affected by obesity and obesity-related co-morbidities, such as Type 2 diabetes, hypertension and more. "The robust discussion by the panel surrounding both the risks and benefits of new obesity drugs is both refreshing and powerful," said Obesity Action Coalition (OAC)...